Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for arthroscopic meniscectomy
ACTRN12618001600235Phase 4Recruiting
- Sponsor
- Prof Gary Hooper
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in meniscal tear comparing Tranexamic acid with Placebo saline (2 arms). Primary endpoints: Pain at 30 days, Swelling at 30 days and 1 more. Started Apr 2018; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
meniscal tear
Beyond the preview
Go deeper on ACTRN12618001600235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001600235.